124 related articles for article (PubMed ID: 38040060)
21. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
22. Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer.
Murofushi K; Yoshioka Y; Sumi M; Ishikawa H; Oguchi M; Sakurai H
Int J Gynecol Cancer; 2020 Apr; 30(4):473-479. PubMed ID: 32165406
[TBL] [Abstract][Full Text] [Related]
23. Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancer.
Trifiletti DM; Grover S; Libby B; Showalter TN
Brachytherapy; 2017; 16(3):547-551. PubMed ID: 28336252
[TBL] [Abstract][Full Text] [Related]
24. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
25. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
26. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
28. External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
Vulpe H; Asamoah FA; Maganti M; Vanderpuye V; Fyles A; Yarney J
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1246-1253. PubMed ID: 29395628
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.
Koukourakis GV; Miliadou A; Tsalafoutas I; Gkeli MG; Sotiropoulou-Lontou A
Clin Transl Oncol; 2013 Feb; 15(2):154-9. PubMed ID: 22855184
[TBL] [Abstract][Full Text] [Related]
30. High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
Yamashita H; Niibe Y; Toita T; Kazumoto T; Nishimura T; Kodaira T; Eto H; Kinoshita R; Tsujino K; Onishi H; Takemoto M; Hayakawa K
Jpn J Clin Oncol; 2013 May; 43(5):547-52. PubMed ID: 23475536
[TBL] [Abstract][Full Text] [Related]
31. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
[TBL] [Abstract][Full Text] [Related]
32. Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.
Petit A; Floquet A; Lasbareilles O; Stoeckle E; Chemin A; Kind M; Guyon F; Brouste V; Pigneux J; Thomas L
Brachytherapy; 2013; 12(6):542-9. PubMed ID: 23880416
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
34. Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy.
Anker CJ; Cachoeira CV; Boucher KM; Rankin J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):704-12. PubMed ID: 19473779
[TBL] [Abstract][Full Text] [Related]
35. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
[TBL] [Abstract][Full Text] [Related]
36. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
[TBL] [Abstract][Full Text] [Related]
37. Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea.
Kim YA; Yang MS; Park M; Choi MG; Kim SY; Kim YJ
J Gynecol Oncol; 2021 Nov; 32(6):e85. PubMed ID: 34431256
[TBL] [Abstract][Full Text] [Related]
38. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Lin AJ; Kidd E; Dehdashti F; Siegel BA; Mutic S; Thaker PH; Massad LS; Powell MA; Mutch DG; Markovina S; Schwarz J; Grigsby PW
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1088-1097. PubMed ID: 30445171
[TBL] [Abstract][Full Text] [Related]
39. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
[TBL] [Abstract][Full Text] [Related]
40. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
